Screener
BBH vs IMCV
VanEck Biotech ETF vs iShares Morningstar Mid-Cap Value ETF
Key differences
Both BBH and IMCV are equity ETFs. BBH charges 0.35% a year and IMCV 0.06%. The main difference: IMCV costs 0.29% less per year.
- IMCV costs 0.29% less per year.
- Over the last three years, IMCV has delivered higher annualized returns.
- IMCV has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BBH | IMCV | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.06% |
| Fund size (AUM) | $367M | $1.0B |
| Since | 2011 | 2004 |
| Dividend yield | 0.51% | 1.95% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +21.9% | +25.1% |
| CAGR 3Y | +6.6% | +16.6% |
| CAGR 5Y | -0.2% | +9.1% |
| Sharpe 3Y | 0.25 | 0.90 |
| Volatility 1Y | 19.41% | 11.75% |
| Max drawdown | -39.86% | -46.33% |
Beyond the comparison: Beacon helps you build, track, and project a portfolio with the ETFs you pick.